Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma

Clinical trial NCT00165217 · COMPLETED

Trial details

NCT number: NCT00165217
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma

Start date: 2001-11-01
Primary completion: 2005-12-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.